Company / Current Assets
KIORA PHARMACEUTICALS INC Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$21.7M
FY2025
5-year range
$1.7M / $29.7M
FY2021-FY2025
Trend
-26.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 8 years, ranging from $2M in FY2021 to $30M in FY2024.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +64.4%.
Improved from $2M to $22M over the past 4 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +64.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +64.4%, indicating consistent growth.
- In FY2025, current assets decreased 26.8% year-over-year.
- Peak current assets was recorded in FY2024.
- Lowest current assets in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.7M | -26.8% |
| FY2024 | $29.7M | +1620.9% |
| FY2021 | $1.7M | -4.6% |
| FY2020 | $1.8M | -58.1% |
| FY2019 | $4.3M | -49.0% |
| FY2018 | $8.5M | +0.2% |
| FY2017 | $8.5M | +103.6% |
| FY2016 | $4.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026